NCT07361146

Brief Summary

This randomized controlled trial aims to compare the effectiveness of two different timings of physical therapy for individuals undergoing hemodialysis: intradialytic (during dialysis) and pre-dialysis (before dialysis). The study seeks to determine which approach provides better improvements in physical function, quality of life, and biochemical outcomes such as hemoglobin and electrolyte levels. A total of 72 adult participants with end-stage renal disease (ESRD) receiving hemodialysis will be randomly assigned to one of two groups. Both groups will receive standardized educational sessions on the benefits and safety of exercise before beginning the intervention. Participants in the intradialytic group will perform supervised exercises during their dialysis sessions, while those in the pre-dialysis group will complete similar exercises before their dialysis sessions. Each participant will undergo the intervention twice per week for 12 weeks. Primary outcomes include physical function, assessed using the Six-Minute Walk Test and the Five Times Sit-to-Stand Test. Secondary outcomes include hemoglobin levels, electrolyte balance, and health-related quality of life measured by the KDQOL questionnaire. The study will be conducted at Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center, Kuwait, following ethical approval from the Ministry of Health Research Ethics Committee. The results are expected to inform best practices for integrating physical therapy into dialysis care to enhance the health, safety, and well-being of individuals undergoing hemodialysis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Mar 2025Jun 2027

Study Start

First participant enrolled

March 2, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2027

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 6, 2026

Last Update Submit

January 14, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Six-Minute Walk Test (6MWT)

    Assessment of functional exercise capacity by measuring the total distance walked in six minutes.

    Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up

  • Quality of Life (Kidney Disease Quality of Life - KDQOL)

    Quality of life assessed using the Kidney Disease Quality of Life (KDQOL) questionnaire.

    Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up

  • Five Times Sit-to-Stand Test (FTSST)

    Assessment of lower limb strength and functional mobility by measuring the time required to complete five sit-to-stand repetitions.

    Baseline, every 4 weeks during the 3-month intervention period, and at 6-month follow-up

Secondary Outcomes (5)

  • Hemoglobin Level

    Baseline, 4 weeks, 8 weeks, and 12 weeks

  • Serum Potassium Level

    Baseline, 4 weeks, 8 weeks, and 12 weeks

  • Serum Sodium Level

    Baseline, 4 weeks, 8 weeks, and 12 weeks

  • Serum Calcium Level

    Baseline, 4 weeks, 8 weeks, and 12 weeks

  • Serum Phosphorus Level

    Baseline, 4 weeks, 8 weeks, and 12 weeks

Study Arms (2)

Intradialytic Physical Therapy (During Dialysis)

EXPERIMENTAL

Participants in this group will perform supervised physical therapy exercises during dialysis sessions twice weekly for 12 weeks (approximately 30 minutes each session, including warm-up, resistance training, and cool-down).

Behavioral: Physical Therapy Exercise Program

Pre-Dialysis Physical Therapy (Before Dialysis)

ACTIVE COMPARATOR

Participants in this group will perform supervised physical therapy exercises before dialysis sessions twice weekly for 12 weeks, following the same exercise protocol and duration as the intradialytic group.

Behavioral: Physical Therapy Exercise Program

Interventions

A structured physical therapy program including warm-up, strengthening, balance, and stretching exercises delivered either during or before hemodialysis sessions (twice weekly for 12 weeks).

Intradialytic Physical Therapy (During Dialysis)Pre-Dialysis Physical Therapy (Before Dialysis)

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 21 and 65 years.
  • Diagnosed with end-stage renal disease (ESRD).
  • Undergoing maintenance hemodialysis for at least 3 months.
  • Medically stable and cleared by the nephrologist to participate in moderate physical exercise.
  • Able to understand and follow verbal instructions and provide informed consent.

You may not qualify if:

  • Uncontrolled hypertension, recent myocardial infarction, or unstable angina.
  • Severe musculoskeletal, neurological, or cardiovascular disorders that limit physical activity.
  • Active infection, fever, or open wounds.
  • Recent hospitalization within the past month.
  • Participation in any other structured exercise program within the last 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center

Hawalli, Kuwait

RECRUITING

MeSH Terms

Conditions

Kidney Failure, ChronicRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 6, 2026

First Posted

January 22, 2026

Study Start

March 2, 2025

Primary Completion (Estimated)

March 2, 2027

Study Completion (Estimated)

June 2, 2027

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations